{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T07:54:06Z","timestamp":1789977246123,"version":"4.0.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","immunology.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology and Allergy Clinics of North America"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.iac.2017.01.008","type":"journal-article","created":{"date-parts":[[2017,3,2]],"date-time":"2017-03-02T04:45:22Z","timestamp":1488429922000},"page":"357-367","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Monoclonal Antibodies for the Treatment of Nasal Polyps"],"prefix":"10.1016","volume":"37","author":[{"given":"Thomas J.","family":"Willson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.","family":"Naclerio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella E.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.iac.2017.01.008_bib1","doi-asserted-by":"crossref","first-page":"392","DOI":"10.2500\/ajra.2009.23.3355a","article-title":"Contemporary assessment of the disease burden of sinusitis","volume":"23","author":"Bhattacharyya","year":"2009","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.iac.2017.01.008_bib2","first-page":"1","article-title":"Summary health statistics for U.S. adults: national health interview survey, 2012","volume":"260","author":"Blackwell","year":"2014","journal-title":"Vital Health Stat 10"},{"issue":"4","key":"10.1016\/j.iac.2017.01.008_bib3","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.jaci.2011.08.004","article-title":"Chronic rhinosinusitis: epidemiology and medical management","volume":"128","author":"Hamilos","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"Suppl 1","key":"10.1016\/j.iac.2017.01.008_bib4","doi-asserted-by":"publisher","first-page":"S22","DOI":"10.1002\/alr.21695","article-title":"International consensus statement on allergy and rhinology: rhinosinusitis","volume":"6","author":"Orlandi","year":"2016","journal-title":"Int Forum Allergy Rhinol"},{"issue":"1","key":"10.1016\/j.iac.2017.01.008_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4193\/Rhino50E2","article-title":"EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists","volume":"50","author":"Fokkens","year":"2012","journal-title":"Rhinology"},{"issue":"5","key":"10.1016\/j.iac.2017.01.008_bib6","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/j.jaci.2010.07.007","article-title":"Presence of IL-5 protein and IgE antibodies to staphylococcal enterotoxins in nasal polyps is associated with comorbid asthma","volume":"126","author":"Bachert","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"7","key":"10.1016\/j.iac.2017.01.008_bib7","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1002\/alr.21315","article-title":"The fate of chronic rhinosinusitis sufferers after maximal medical therapy","volume":"4","author":"Baguley","year":"2014","journal-title":"Int Forum Allergy Rhinol"},{"issue":"4","key":"10.1016\/j.iac.2017.01.008_bib8","doi-asserted-by":"publisher","first-page":"396","DOI":"10.2500\/ajra.2009.23.3334","article-title":"Efficacy of targeted medical therapy in chronic rhinosinusitis, and predictors of failure","volume":"23","author":"Lal","year":"2009","journal-title":"Am J Rhinol Allergy"},{"issue":"1","key":"10.1016\/j.iac.2017.01.008_bib9","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1939-4551-7-25","article-title":"ICON: chronic rhinosinusitis","volume":"7","author":"Bachert","year":"2014","journal-title":"World Allergy Organ J"},{"issue":"Suppl 7","key":"10.1016\/j.iac.2017.01.008_bib10","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1002\/lary.24418","article-title":"Analysis of comorbidities and objective parameters in refractory chronic rhinosinusitis","volume":"123","author":"Batra","year":"2013","journal-title":"Laryngoscope"},{"issue":"7","key":"10.1016\/j.iac.2017.01.008_bib11","doi-asserted-by":"publisher","first-page":"e0127228","DOI":"10.1371\/journal.pone.0127228","article-title":"Airway inflammation in chronic rhinosinusitis with nasal polyps and asthma: the united airways concept further supported","volume":"10","author":"Hakansson","year":"2015","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.iac.2017.01.008_bib12","doi-asserted-by":"publisher","first-page":"243","DOI":"10.2500\/108854196778662255","article-title":"The clinical relationship of nasal polyps to asthma","volume":"17","author":"Larsen","year":"1996","journal-title":"Allergy Asthma Proc"},{"issue":"4","key":"10.1016\/j.iac.2017.01.008_bib13","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1002\/alr.21674","article-title":"Prevalence of confirmed asthma varies in chronic rhinosinusitis subtypes","volume":"6","author":"Promsopa","year":"2016","journal-title":"Int Forum Allergy Rhinol"},{"issue":"5","key":"10.1016\/j.iac.2017.01.008_bib14","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1177\/019459989411100508","article-title":"Diagnosis of allergic fungal sinusitis","volume":"111","author":"Bent","year":"1994","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"5 Pt 1","key":"10.1016\/j.iac.2017.01.008_bib15","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1097\/00005537-200005000-00010","article-title":"Eosinophilic mucin rhinosinusitis: a distinct clinicopathological entity","volume":"110","author":"Ferguson","year":"2000","journal-title":"Laryngoscope"},{"issue":"2 Suppl 2","key":"10.1016\/j.iac.2017.01.008_bib16","doi-asserted-by":"publisher","first-page":"S73","DOI":"10.1016\/j.jaci.2009.11.017","article-title":"IgE, mast cells, basophils, and eosinophils","volume":"125","author":"Stone","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.iac.2017.01.008_bib17","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/j.jaci.2006.05.031","article-title":"Nasal IL-5 levels determine the response to anti-IL-5 treatment in patients with nasal polyps","volume":"118","author":"Gevaert","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.iac.2017.01.008_bib18","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.jaip.2014.09.022","article-title":"Clinical characteristics of adults with chronic rhinosinusitis and specific antibody deficiency","volume":"3","author":"Kashani","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.iac.2017.01.008_bib19","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1016\/j.jaci.2015.10.010","article-title":"Current and future treatment options for adult chronic rhinosinusitis: focus on nasal polyposis","volume":"136","author":"Bachert","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.iac.2017.01.008_bib20","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1164\/rccm.201212-2227OC","article-title":"IL-33-responsive innate lymphoid cells are an important source of IL-13 in chronic rhinosinusitis with nasal polyps","volume":"188","author":"Shaw","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.iac.2017.01.008_bib21","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.jaci.2013.04.005","article-title":"Thymic stromal lymphopoietin activity is increased in nasal polyps of patients with chronic rhinosinusitis","volume":"132","author":"Nagarkar","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"7534","key":"10.1016\/j.iac.2017.01.008_bib22","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/nature14189","article-title":"The biology of innate lymphoid cells","volume":"517","author":"Artis","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.iac.2017.01.008_bib23","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13601-015-0076-5","article-title":"The role of IL-33 and mast cells in allergy and inflammation","volume":"5","author":"Saluja","year":"2015","journal-title":"Clin Transl Allergy"},{"issue":"1","key":"10.1016\/j.iac.2017.01.008_bib24","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/2049-6958-9-23","article-title":"Treating severe allergic asthma with anti-IgE monoclonal antibody (omalizumab): a review","volume":"9","author":"D'Amato","year":"2014","journal-title":"Multidiscip Respir Med"},{"issue":"6","key":"10.1016\/j.iac.2017.01.008_bib25","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/j.jaci.2003.10.003","article-title":"Omalizumab treatment downregulates dendritic cell FcepsilonRI expression","volume":"112","author":"Prussin","year":"2003","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.iac.2017.01.008_bib26","doi-asserted-by":"publisher","first-page":"346","DOI":"10.2500\/aap.2011.32.3467","article-title":"Clinical efficacy of omalizumab in an elderly veteran population with severe asthma","volume":"32","author":"Verma","year":"2011","journal-title":"Allergy Asthma Proc"},{"issue":"3","key":"10.1016\/j.iac.2017.01.008_bib27","doi-asserted-by":"crossref","first-page":"318","DOI":"10.4193\/Rhin09.144","article-title":"A\u00a0randomized, double-blind, placebo-controlled trial of anti-IgE for chronic rhinosinusitis","volume":"48","author":"Pinto","year":"2010","journal-title":"Rhinology"},{"issue":"1","key":"10.1016\/j.iac.2017.01.008_bib28","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jaci.2012.07.047","article-title":"Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma","volume":"131","author":"Gevaert","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.iac.2017.01.008_bib29","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1002\/alr.21685","article-title":"Impact of omalizumab therapy on medication requirements for chronic rhinosinusitis","volume":"6","author":"Chandra","year":"2016","journal-title":"Int Forum Allergy Rhinol"},{"issue":"6","key":"10.1016\/j.iac.2017.01.008_bib30","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/j.jaci.2007.09.032","article-title":"American Academy of Allergy, Asthma & Immunology\/American College of Allergy, Asthma and Immunology Joint Task Force Report on omalizumab-associated anaphylaxis","volume":"120","author":"Cox","year":"2007","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.iac.2017.01.008_bib31","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.jaci.2011.04.010","article-title":"American Academy of Allergy, Asthma & Immunology\/American College of Allergy, Asthma & Immunology Omalizumab-Associated Anaphylaxis Joint Task Force follow-up report","volume":"128","author":"Cox","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.iac.2017.01.008_bib32","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.jaci.2014.02.007","article-title":"Incidence of malignancy in patients with moderate-to-severe asthma treated with or without omalizumab","volume":"134","author":"Long","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.iac.2017.01.008_bib33","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.jaci.2011.07.056","article-title":"Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposis","volume":"128","author":"Gevaert","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2017.01.008_bib34","series-title":"ClinicalTrials.gov [internet]","article-title":"A\u00a0two-part, randomised, double-blind, placebo controlled, multi-center study to investigate the use of mepolizumab (Sb-240563) in reducing the need for surgery in subjects with severe bilateral nasal polyposis","author":"GSK Clinical Trials","year":"2011"},{"issue":"6","key":"10.1016\/j.iac.2017.01.008_bib35","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1016\/j.jaci.2010.04.004","article-title":"MEDI-563, a humanized anti-IL-5 receptor alpha mAb with enhanced antibody-dependent cell-mediated cytotoxicity function","volume":"125","author":"Kolbeck","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2017.01.008_bib36","series-title":"ClinicalTrials.gov [Internet]","article-title":"An evaluation of dupilumab in patients with nasal polyposis and chronic symptoms of sinusitis","author":"Sanofi","year":"2013"},{"issue":"5","key":"10.1016\/j.iac.2017.01.008_bib37","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1001\/jama.2015.19330","article-title":"Effect of subcutaneous dupilumab on nasal polyp burden in patients with chronic sinusitis and nasal polyposis: a randomized clinical trial","volume":"315","author":"Bachert","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.iac.2017.01.008_bib38","series-title":"ClinicalTrials.gov [internet]","article-title":"Study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of AMG 282 in healthy subjects and subjects with chronic rhinosinusitis with nasal polyps","author":"Amgen","year":"2014"},{"issue":"3","key":"10.1016\/j.iac.2017.01.008_bib39","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.pharmthera.2012.06.005","article-title":"Siglec-8 as a drugable target to treat eosinophil and mast cell-associated conditions","volume":"135","author":"Kiwamoto","year":"2012","journal-title":"Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.iac.2017.01.008_bib40","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/lary.24916","article-title":"Economic evaluation of endoscopic sinus surgery versus continued medical therapy for refractory chronic rhinosinusitis","volume":"125","author":"Rudmik","year":"2015","journal-title":"Laryngoscope"}],"container-title":["Immunology and Allergy Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856117300085?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856117300085?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T03:07:22Z","timestamp":1568862442000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889856117300085"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S0889856117300085"],"URL":"https:\/\/doi.org\/10.1016\/j.iac.2017.01.008","relation":{},"ISSN":["0889-8561"],"issn-type":[{"value":"0889-8561","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Monoclonal Antibodies for the Treatment of Nasal Polyps","name":"articletitle","label":"Article Title"},{"value":"Immunology and Allergy Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iac.2017.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}